CD4 and CD8 T lymphocyte interplay in controlling tumor growth
Open Access
- 14 October 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cellular and Molecular Life Sciences
- Vol. 75 (4), 689-713
- https://doi.org/10.1007/s00018-017-2686-7
Abstract
The outstanding clinical success of immune checkpoint blockade has revived the interest in underlying mechanisms of the immune system that are capable of eliminating tumors even in advanced stages. In this scenario, CD4 and CD8 T cell responses are part of the cancer immune cycle and both populations significantly influence the clinical outcome. In general, the immune system has evolved several mechanisms to protect the host against cancer. Each of them has to be undermined or evaded during cancer development to enable tumor outgrowth. In this review, we give an overview of T lymphocyte-driven control of tumor growth and discuss the involved tumor-suppressive mechanisms of the immune system, such as senescence surveillance, cancer immunosurveillance, and cancer immunoediting with respect to recent clinical developments of immunotherapies. The main focus is on the currently existing knowledge about the CD4 and CD8 T lymphocyte interplay that mediates the control of tumor growth.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (WO 1933/1-2)
This publication has 177 references indexed in Scilit:
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerThe New England Journal of Medicine, 2012
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerThe New England Journal of Medicine, 2012
- Expression of tumour-specific antigens underlies cancer immunoeditingNature, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC developmentBritish Journal of Cancer, 2010
- Distinct MHC gene expression patterns during progression of melanomaGenes, Chromosomes and Cancer, 2009
- Distinct regulation of interleukin‐17 in human T helper lymphocytesArthritis & Rheumatism, 2007
- TH-17 cells in the circle of immunity and autoimmunityNature Immunology, 2007
- Intrinsic tumour suppressionNature, 2004
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002